Verition Fund Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Verition Fund Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33,790	Closed	-$1.21M	–	2776
2022 Q4	$1.21M	Buy	+33,790	New	+$845K	0.02%	834

Verition Fund Management's IMGO Position: Q1 2023 in Review

Verition Fund Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 33,790 shares — an estimated $1.21M sold.

Verition Fund Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $1.21M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Verition Fund Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Verition Fund Management sold 33,790 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.21M.
Verition Fund Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Verition Fund Management's Imago BioSciences, Inc. Common stock position peaked at $1.21M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.